Vitality Biopharma (VBIO) Starts Presentation at LD Micro Main Event
Vitality Biopharma (OTCQB: VBIO) is focused on leveraging the power of cannabinoids to treat serious neurological and inflammatory disorders. The company has developed a new class of cannabinoid prodrugs (cannabosides), which upon ingestion can enable the selective delivery of THC and cannabidiol (CBD) to the gastrointestinal tract. Site-specific delivery could enable oral drug formulations of cannabinoids to provide therapeutic benefits while reducing or avoiding the systemic delivery of THC into the bloodstream. Currently, high concentrations of psychoactive THC in the brain limit the dose of cannabinoids that can be used elsewhere in the body for treatment of pain and inflammation.…
